High Grade Astrocytic Tumor — Trials

High Grade Astrocytic Tumor — Trials · CancerIndex

Clinical trials

Registered studies

1,778 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 495
Recruiting: 263
Ph III recruiting: 15
Growth YoY: +41.8%
Industry share: 19%
Top sponsor: National Cancer Institute (NCI)
Termination share: 34%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (282)

clinicaltrialsPublishedShowing 651–700 of 1,778 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04006119	Study of Ad-RTS-hIL-12 + Veledimex in Combination With Cemiplimab in Subjects With Recurrent or Progressive Glioblastoma	terminated	Phase 2	40	Alaunos TherapeuticsINDUSTRY	1	Apr 18, 2025	clinicaltrials
NCT02026271	A Study of Ad-RTS-hIL-12 With Veledimex in Subjects With Glioblastoma or Malignant Glioma	completed	Phase 1	40	Alaunos TherapeuticsINDUSTRY	1	Apr 16, 2025	clinicaltrials